رجوع
نطاق اليوم
KWD 14.00
KWD 14.00
نطاق 52 أسبوعًا
KWD 14.00
KWD 14.00
حجم التداول
100
متوسط 50 يوم / 200 يوم
KWD 14.00
/
KWD 14.00
الإغلاق السابق
KWD 14.00
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 0.1 | 0.4 |
| P/B | 0.0 | 2.9 |
| ROE % | 12.5 | 3.8 |
| Net Margin % | 7.9 | 3.9 |
| Rev Growth 5Y % | 6.2 | 10.0 |
| D/E | 0.1 | 0.2 |
السعر المستهدف للمحللين
لا تتوفر تغطية محللين
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 0.000
KWD 0.000 – KWD 0.000
|
130 B | 0 |
| FY2029 |
KWD 0.000
KWD 0.000 – KWD 0.000
|
130 B | 0 |
| FY2028 |
KWD 145.961
KWD 143.516 – KWD 150.739
|
120 B | 1 |
النقاط الرئيسية
Revenue grew 6.19% annually over 5 years — modest growth
ROE of 12.53% — decent returns on equity
Debt/Equity of 0.11 — conservative balance sheet
Generating 7.52B in free cash flow
P/E of 0.12 — trading at a low valuation
Cash machine — converts 91.41% of earnings into free cash flow
النمو
Revenue Growth (5Y)
6.19%
Revenue (1Y)8.60%
Earnings (1Y)9.72%
FCF Growth (3Y)13.72%
الجودة
Return on Equity
12.53%
ROIC11.77%
Net Margin7.93%
Op. Margin11.17%
الأمان
Debt / Equity
0.11
Current Ratio2.64
Interest Coverage1449.13
التقييم
P/E Ratio
0.12
P/B Ratio0.01
EV/EBITDA-1.24
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8.60% | Revenue Growth (3Y) | 6.53% |
| Earnings Growth (1Y) | 9.72% | Earnings Growth (3Y) | 0.71% |
| Revenue Growth (5Y) | 6.19% | Earnings Growth (5Y) | 8.27% |
| Profitability | |||
| Revenue (TTM) | 103.75B | Net Income (TTM) | 8.23B |
| ROE | 12.53% | ROA | 8.22% |
| Gross Margin | 30.18% | Operating Margin | 11.17% |
| Net Margin | 7.93% | Free Cash Flow (TTM) | 7.52B |
| ROIC | 11.77% | FCF Growth (3Y) | 13.72% |
| Safety | |||
| Debt / Equity | 0.11 | Current Ratio | 2.64 |
| Interest Coverage | 1449.13 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 0.12 | P/B Ratio | 0.01 |
| P/S Ratio | 0.01 | PEG Ratio | 2.79 |
| EV/EBITDA | -1.24 | Dividend Yield | 0.02% |
| Market Cap | 997.73M | Enterprise Value | -14.39B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 103.75B | 95.54B | 91.42B | 86.95B | 81.61B |
| Net Income | 8.23B | 7.50B | 8.11B | 7.20B | 5.99B |
| EPS (Diluted) | 114.87 | 103.50 | 109.30 | 96.21 | 80.03 |
| Gross Profit | 31.32B | 29.25B | 28.45B | 25.54B | 25.93B |
| Operating Income | 11.59B | 10.44B | 11.40B | 9.34B | 9.89B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 100.14B | 95.83B | 97.48B | 96.11B | 94.23B |
| Total Liabilities | 33.43B | 31.17B | 33.51B | 29.95B | 31.46B |
| Shareholders' Equity | 66.71B | 64.66B | 63.97B | 66.15B | 62.76B |
| Total Debt | 7.19B | 3.60B | 6.19B | 3.10B | 4.70B |
| Cash & Equivalents | 22.57B | 13.19B | 17.61B | 18.72B | 14.35B |
| Current Assets | 69.96B | 61.23B | 62.66B | 59.90B | 58.72B |
| Current Liabilities | 26.49B | 26.10B | 27.31B | 25.72B | 25.60B |
درجات الاستراتيجيات
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
النشاط الأخير
دخل
Cash Flow Compounder
Mar 24, 2026
دخل
Deep Value Investing (Seth Klarman)
Mar 24, 2026
دخل
Defensive Investing (Benjamin Graham)
Mar 24, 2026